Remdesivir as a possible therapeutic option for the COVID-19
- PMID: 32145386
- PMCID: PMC7129391
- DOI: 10.1016/j.tmaid.2020.101615
Remdesivir as a possible therapeutic option for the COVID-19
Conflict of interest statement
Declaration of competing interest All authors have no conflicts of interest.
Comment on
-
MERS-CoV as an emerging respiratory illness: A review of prevention methods.Travel Med Infect Dis. 2019 Nov-Dec;32:101520. doi: 10.1016/j.tmaid.2019.101520. Epub 2019 Nov 12. Travel Med Infect Dis. 2019. PMID: 31730910 Free PMC article. Review.
References
-
- World Health Organization . 2020. Situation Report-17 SITUATION IN NUMBERS total and new cases in last 24 hours.https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
-
- Warren T., Jordan R., Lo M., Soloveva V., Ray A., Bannister R. Nucleotide prodrug GS-5734 is a broad-spectrum filovirus inhibitor that provides complete therapeutic protection against the development of Ebola virus disease (EVD) in infected non-human primates. Open Forum Infect Dis. 2015;2 doi: 10.1093/ofid/ofv130.02. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources